| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 159.583 | 175.500 | 154.537 | 317.298 |
| Total Income - EUR | - | - | - | - | - | - | 176.863 | 228.854 | 274.521 | 536.557 |
| Total Expenses - EUR | - | - | - | - | - | - | 96.151 | 176.710 | 271.796 | 486.824 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 80.712 | 52.144 | 2.724 | 49.733 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 78.684 | 51.212 | 2.064 | 47.474 |
| Employees | - | - | - | - | - | - | 1 | 3 | 4 | 4 |
Check the financial reports for the company - Mavit Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 14.940 | 73.567 | 141.648 | 181.480 |
| Current Assets | - | - | - | - | - | - | 272.266 | 417.047 | 516.013 | 839.348 |
| Inventories | - | - | - | - | - | - | 222.393 | 313.168 | 418.771 | 765.397 |
| Receivables | - | - | - | - | - | - | 24.713 | 89.539 | 89.428 | 64.479 |
| Cash | - | - | - | - | - | - | 25.160 | 14.340 | 7.813 | 9.472 |
| Shareholders Funds | - | - | - | - | - | - | 78.725 | 130.181 | 131.850 | 178.588 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 208.482 | 360.432 | 525.810 | 842.241 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "142 - 142" | |||||||||
| CAEN Financial Year |
142
|
|||||||||
Comments - Mavit Bio S.r.l.